Calendar

Financial releases

Date Title  
Toggle Summary AbbVie to Host Fourth-Quarter and Full-Year 2019 Earnings Conference Call
NORTH CHICAGO, Ill. , Jan. 13, 2020 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will announce its fourth-quarter and full-year 2019 financial results on Friday, February 7, 2020 before the market opens. AbbVie will host a live webcast of the earnings
Toggle Summary AbbVie to Present at the 38th Annual J.P. Morgan Healthcare Conference
NORTH CHICAGO, Ill. , Jan. 3, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020 . Richard A. Gonzalez , chairman and chief executive officer, will present
Toggle Summary AbbVie Reports Third-Quarter 2019 Financial Results
- Reports Third-Quarter Diluted EPS of $1.26 on a GAAP Basis; Adjusted Diluted EPS of $2.33 - Third-Quarter Net Revenues Were $8.479 Billion, an Increase of 3.0 Percent on a GAAP Basis, or 3.5 Percent Operationally - Third-Quarter U.S. HUMIRA Net Revenues Were $3.887 Billion, an Increase of 9.6
Toggle Summary AbbVie to Present at the Wolfe Research Inaugural Healthcare Conference
NORTH CHICAGO, Ill. , Oct. 24, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Wolfe Research Inaugural Healthcare Conference on Wednesday, November 6.  Richard A. Gonzalez , chairman and chief executive officer, will present at
Toggle Summary AbbVie to Host Third-Quarter 2019 Earnings Conference Call
  NORTH CHICAGO, Ill. , Oct. 8, 2019 /PRNewswire/ --   AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will announce its third-quarter 2019 financial results on Friday, November 1 before the market opens. AbbVie will host a live webcast of the earnings conference call at 8
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , Sept. 6, 2019 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $1.07 per share.  The cash dividend is payable November 15, 2019 to stockholders of record at the close of business on October 15, 2019 .
Toggle Summary AbbVie to Present at the Morgan Stanley Healthcare Conference
NORTH CHICAGO, Ill. , Aug. 27, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Morgan Stanley 17 th Annual Global Healthcare Conference on Tuesday, September 10 , 2019.  Richard A. Gonzalez , chairman and chief executive officer,
Toggle Summary AbbVie Reports Second-Quarter 2019 Financial Results
- Announced a Definitive Transaction Agreement to Acquire Allergan, Significantly Expanding and Diversifying AbbVie's Revenue Base with New Therapeutic Areas and Enhancing Long-Term R&D Funding Capacity to Allow for Continued Investment in Innovative Science - Reports Second-Quarter Diluted EPS of
Toggle Summary AbbVie to Host Second-Quarter 2019 Earnings Conference Call
NORTH CHICAGO, Ill. , July 11, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will announce its second-quarter 2019 financial results on Friday, July 26 before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m.
Toggle Summary AbbVie to Acquire Allergan in Transformative Move for Both Companies
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION THIS ANNOUNCEMENT IS BEING MADE PURSUANT TO RULE 2.5 OF THE IRISH TAKEOVER RULES - Provides